Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial.
about
Management of antithrombotic therapy during cardiac implantable device surgeryReversal of oral anticoagulationGuidance for the practical management of warfarin therapy in the treatment of venous thromboembolismPrescribing warfarin appropriately to meet patient safety goals.Warfarin and vitamin K intake in the era of pharmacogenetics.Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.A retrospective evaluation of vitamin K1 therapy to reverse the anticoagulant effect of warfarin.Incidence, clinical impact and risk of bleeding during oral anticoagulation therapyLow-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: a brief review.Practical challenges in the management of oral anticoagulation.Surgical delay in acute admissions on warfarin: are we doing enough?Haemorrhagic complications of vitamin k antagonists in the elderly: risk factors and management.Reversal of asymptomatic over-anticoagulation by orally administered vitamin K.Perioperative management of patients receiving vitamin K antagonists.Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms.Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimen.The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians.Warfarin reversal in anticoagulant-associated intracerebral hemorrhage.Central venous thrombosis in patients receiving long-term parenteral nutrition.Management of surgical patients receiving anticoagulation and antiplatelet agents.Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment.Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention.Epidemiology and management of bleeding in patients using vitamin K antagonists.Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient.Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure.Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents.Treatment of warfarin-associated coagulopathy with vitamin K.Blood component support in acquired coagulopathic conditions: is there a method to the madness?Reversal of drug-induced anticoagulation: old solutions and new problems.Is bleeding a necessary evil? The inherent risk of antithrombotic pharmacotherapy used for stroke prevention in atrial fibrillation.Anticoagulation management in individuals with hip fracture.Activated prothrombin complex concentrates for the reversal of anticoagulant-associated coagulopathy.Warfarin Re-initiation Gone Awry: A Case of Inadvertent Overdose Mandating Critical INR Management.The effectiveness and safety of fixed low-dose prothrombin complex concentrates in patients requiring urgent reversal of warfarin.Emergency reversal of antithrombotic treatment.Adherence to guidelines for the management of excessive warfarin anticoagulation.Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases.Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines.Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists?Administration of Injectable Vitamin K Orally.
P2860
Q26746160-4C84DEBF-284E-47C7-BF20-65F8EB457BF0Q26827835-86997DFE-1FA4-419B-99A2-291625BA8F53Q28066527-2D6833BD-6D57-43AA-AAD6-15393D63392DQ33932089-540FB947-74C3-4170-8774-1E66C448B12DQ34026225-51FE1CED-61A1-4D19-A8F9-A6CAA9FCB25FQ34252907-29F392AD-CE9A-4CAF-86DF-DC4388833C39Q35574012-F13BE062-5D5F-4D51-9023-7B01EB13AEB8Q35575180-C932A4ED-A4C0-40B3-BAFC-CEF818043C72Q35679289-E12277F8-DA99-459E-80A0-F9AE73EA2210Q36123496-7E8B234F-DAD8-4228-98C1-346ABB8FAE0AQ36291017-8C817972-38E0-43AE-A18E-838E6B4C85DFQ36402506-FAAABAAC-74CA-4209-9408-AFD728675E3BQ36462088-4C7AC463-D42F-4CA8-8D26-103896268EFCQ36503057-B0640332-0DDE-48A8-9495-722933014643Q36589312-739AAFD7-C4DF-4EA7-AE33-1D6CEE9D48E7Q36624112-3372C3B9-8198-47E8-87BF-4F53DAEE2E64Q36656202-613F7D24-CB9C-4998-B520-821EEA221A9BQ37063465-BCDA1DE0-0394-4268-A9A7-AC97B829A4BEQ37112540-0F2969E6-2E68-4270-BC77-886B88BBFAF2Q37320021-8933F966-40C0-408D-9F2F-51BE44AE29E7Q37554147-2647638C-D819-4936-BFB4-56F25F33B8DEQ37554153-1836311B-9520-4503-BF1C-3D07A163A850Q37561480-F87138C1-6FE7-4DBA-8885-713C6120E6BEQ37625900-A4C86DC2-990B-4115-8766-4CDC599373F9Q37832976-A0E6A01E-E207-4383-8BD9-175BEA5D1ED0Q37897674-0297667D-969B-4245-9652-B4EA25C43B5FQ37955232-E0B6F4D4-A7A4-4180-83DE-19BD4ADB44F6Q37999723-5EFE3E14-71D0-4FF7-946F-59D4213F4D68Q38009420-821A6935-6E9D-440B-8675-5891BEA6F28FQ38132255-EA961039-8091-4613-8B05-6E156FE50683Q38175194-749899D3-1F94-4DD5-897A-8D50D37AFCFCQ38175956-857AA8BF-56B1-4888-AC51-74000C0BCDEBQ40069690-C581B606-EFEA-4675-96DA-12B44507E4E2Q44241618-4D504F2E-7C5A-43DF-B3B6-98A3881E5987Q46252055-767294E3-9FFA-4367-B8AF-E4EEC2FE6CCCQ46606035-AEB5371F-A78D-4595-9D66-B298371AFA3FQ46704454-066B678E-1114-4F18-9721-D4CC248A5CFFQ48248862-F8C82455-B713-4591-A6F8-8E71D5935562Q48397506-41094652-27DD-4ED2-967B-53F9C0290D29Q49586884-10A55C6F-93A9-4B1B-AE82-6D1C1B6BC4A6
P2860
Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Oral vitamin K lowers the inte ...... randomized, controlled trial.
@ast
Oral vitamin K lowers the inte ...... randomized, controlled trial.
@en
Oral vitamin K lowers the inte ...... randomized, controlled trial.
@nl
type
label
Oral vitamin K lowers the inte ...... randomized, controlled trial.
@ast
Oral vitamin K lowers the inte ...... randomized, controlled trial.
@en
Oral vitamin K lowers the inte ...... randomized, controlled trial.
@nl
prefLabel
Oral vitamin K lowers the inte ...... randomized, controlled trial.
@ast
Oral vitamin K lowers the inte ...... randomized, controlled trial.
@en
Oral vitamin K lowers the inte ...... randomized, controlled trial.
@nl
P2093
P1476
Oral vitamin K lowers the inte ...... randomized, controlled trial.
@en
P2093
Achille Venco
Carolina Ultori
James D Douketis
Luigi Steidl
Mark A Crowther
Terri Schnurr
Valentina Mera
Walter Ageno
P304
P356
10.7326/0003-4819-137-4-200208200-00009
P407
P577
2002-08-01T00:00:00Z